Fluent by Cansortium Opens New Dispensary in Fruitland Park, Florida
Fluent by Cansortium Opens New Dispensary in Fruitland Park, Florida PR Newswire MIAMI , Sept. 16, 2021 /PRNewswire/ – Fluent by Cansortium Inc. (CSE: TIUM.U) (OTCQX: CNTMF) (“Fluent,” “Cansortium,” or the “Company”), a vertically-integrated cannabis more...
Neovasc Announces FDA Approval of COSIRA-II Clinical Trial
Company on Schedule to Commence Trial Late This Year Vancouver, British Columbia and Minneapolis, Minnesota–(Newsfile Corp. – September 16, 2021) – Neovasc Inc. (NASDAQ: NVCN) (TSX: NVCN) (“Neovasc” or the “Company”) announced today that it more...
Altiplano Obtains Exploitation Permit at Maria Luisa
Edmonton, Alberta–(Newsfile Corp. – September 16, 2021) – Altiplano Metals Inc. (TSXV: APN) (WKN: A2JNFG) (“Altiplano” or the “Company”) is pleased to announce that the Exploitation Permit Application for the Maria Luisa historical Gold-Copper mine more...
INVESTOR ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Annovis Bio, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 16, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Annovis Bio, Inc. (“Annovis” or “the Company”) more...
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
First international patient enrolled in Brazil Trial approximately 75% enrolled rNAPc2 development focused on unmet need for treatments in hospitalized COVID-19 patients Topline trial data anticipated in the fourth quarter of 2021 WESTMINSTER, Colo., Sept. more...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Emerging as Leader in Pursuit of More-Effective Hypertension Treatment
NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) — NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Hypertension: The Silent Killer Making Loud Noise for Investors.” To hear the AudioPressRelease, please more...
Aileron Therapeutics Presents New Clinical Data at ESMO Virtual Congress 2021 Supporting ALRN-6924’s Best-in-Class Potential as a Chemoprotective Agent
Final results from completed Phase 1b trial in patients with small cell lung cancer (SCLC) receiving second-line topotecan demonstrated ALRN-6924’s ability to reduce neutropenia, thrombocytopenia and anemia caused by chemotherapy, as well as the need more...
Lightbridge Receives Notice of Allowance for Key Patent in Japan
RESTON, Va., Sept. 16, 2021 (GLOBE NEWSWIRE) — Lightbridge Corporation (Nasdaq: LTBR), an advanced nuclear fuel technology company, today announced that it received a Notice of Allowance for a key divisional patent in Japan related more...
Study Finds the Combination of Optical Genome Mapping and Short-Read Sequencing Provides a Comprehensive Genome Analysis for Lung Cancer Samples and Enables the Discovery of New Biomarkers
SAN DIEGO, Sept. 16, 2021 (GLOBE NEWSWIRE) — Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a study finding the combination of optical genome mapping (OGM) and short-read next-generation sequencing (NGS) provides a comprehensive genome analysis more...
Seven Abstracts to be Presented on Evofem Biosciences’ Vaginal pH Modulator
Seven Abstracts to be Presented on Evofem Biosciences’ Vaginal pH Modulator PR Newswire SAN DIEGO , Sept. 16, 2021 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced that seven data sets from clinical trials of Phexxi® more...